Unchalee Kositprapa, based in Davie, FL, is a distinguished inventor with a remarkable portfolio of 15 patents. His innovative contributions primarily focus on pharmaceutical formulations, showcasing his expertise in creating effective drug delivery systems.

Latest Patents

Among his latest patents, Kositprapa has developed a pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative. This invention describes a pharmaceutical dosage form that includes a controlled release component comprising an antihyperglycemic drug, combined with a thiazolidinedione derivative. Additionally, he has patented a rapidly disintegrating antihistamine formulation, designed for oral administration. This formulation is engineered to dissolve in the buccal cavity of the patient, providing an efficient means of drug delivery.

Career Highlights

Throughout his career, Kositprapa has worked with notable companies such as Andrx Pharmaceuticals, Inc. and Watson Pharmaceuticals, Inc., contributing to the development of innovative pharmaceutical products. His extensive experience in the pharmaceutical industry has positioned him as a key player in the field of drug formulation.

Collaborations

Collaboration has played a significant role in Kositprapa's success. He has worked alongside esteemed coworkers like Chih-Ming Chen and Avinash Nangia, sharing insights and expertise to further advance his inventions and patents.

Conclusion

Unchalee Kositprapa stands out as a prominent inventor in the realm of pharmaceutical innovations. His substantial contributions through patents not only highlight his inventive prowess but also signify his impact on the pharmaceutical industry’s evolution. As he continues to innovate, Kositprapa remains a significant figure in advancing effective drug delivery solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com